Skin diseases in diabetes mellitus;Hauterkrankungen bei diabetes mellitus

JDDG - Journal of the German Society of Dermatology

Volumn 5, Issue 1, 2007, Pages 37-53

  Wohlrab, Johannes ^a,b   Wohlrab, David ^a   Meiss, Frank ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANTIDIABETIC AGENT; CHLORPROPAMIDE; DEXAMETHASONE; DISULFIRAM; GLIBENCLAMIDE; INSULIN; N ACETYLGLUCOSAMINE; PHOSPHOTRANSFERASE; SORBITOL; SULFONYLUREA DERIVATIVE; TOLBUTAMIDE;

ALCOHOL TOLERANCE; ARTICLE; BEHAVIOR THERAPY; BLISTER; CANDIDA ALBICANS; DERMATOMYCOSIS; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC FOOT; DIABETIC RETINOPATHY; DRUG HYPERSENSITIVITY; ERYTHEMA; EXFOLIATION SYNDROME; GLUCOSE TRANSPORT; HUMAN; HYPERGLYCEMIA; HYPERTRICHOSIS; IMMUNOPATHOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LIPOATROPHY; LIPOHYPERTROPHY; LOW DRUG DOSE; MACULOPAPULAR RASH; MATURITY ONSET DIABETES MELLITUS; MEASLES LIKE RASH; METABOLIC DISORDER; NECROBIOTIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ONYCHOMYCOSIS; PAPULE; PIGMENT DISORDER; PREGNANCY DIABETES MELLITUS; PRURITUS; PURPURA; SCLERODERMA; SIDE EFFECT; SKIN ATROPHY; SKIN DISEASE; SKIN INFECTION; STEROID DIABETES; STEVENS JOHNSON SYNDROME; TYPE A INSULIN RESISTANCE; URTICARIA;

EID: 33846180039     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2007.06073.x     Document Type: Article

References (12)

1. Gutteridge IF. Diabetes mellitus: a brief history, epidemiology, definition and classification. Clin Exp Optom 1999; 82: 102-106.
2. Passa P. Diabetes trends in Europe. Diabetes Metab Res Rev 2002; 18: 3-8.
3. WHO Expert Commetee. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation 1999; part 1.
4. Hauner H. Verbreitung des Diabetes mellitus in Deutschland. Dtsch Med Wochenschr 1998; 123: 777-782.
5. Horenstein RB, Shuldiner AR. Genetics of diabetes. Rev Endocr Metab Disord 2004; 5: 25-36.
6. Wautier JL, Guillausseau PJ. Advanced glycation end products, their receptors and diabetic angiopathy. Diabetes Metab 2001; 27: 535-542.
7. Obrosova IG. Increased sorbitol pathway activity generates oxidative stress in tissue sites for diabetic complications. Antioxid Redox Signal 2005; 7: 1543-1552.
8. Buse MG. Hexosamines, insulin resistance, and the complications of diabetes: current status. Am J Physiol Endocrinol Metab 2006; 290: E1-E8.
9. Sarabu R, Grimsby J. Targeting glucokinase activation for the treatment of type 2 diabetes - a status review. Curr Opin Drug Discov Devel 2005; 8: 631-637.
10. Huntley AC. Cutaneous manifestations of diabetes mellitus. Dermatol Clin 1989; 7: 531-546.
11. Meurer M, Stumvoll M, Szeimies RM. Hautveränderungen bei Diabetes mellitus. Hautarzt 2004; 55: 428-435.
12. Sullivan KA, Feldman EL. New developments in diabetic neuropathy. Curr Opin Neurol 2005; 18: 586-590.